Academic Appointments

Honors & Awards

  • Bridge to K Instructor Program, Department of Pediatrics, Stanford University School of Medicine (2019-2022)
  • Jared J. Grantham Research Fellowship, American Society of Nephrology Research Foundation (2019-2021)
  • Alpha Omega Alpha, Stanford University School of Medicine (2019)
  • Celebrate Life Award, Georgia Transplant Foundation (2019)
  • Hero of Hope Award, American Kidney Fund (2019)
  • Ernst and Amelia Gallo Endowed Postdoctoral Fellowship, Maternal and Child Health Research Institute, Stanford Children's Health (2017-2019)
  • Anne Elizabeth and Harper Gaston Service Scholarship, Emory University School of Medicine (2012-2013)
  • Meg Jeffrey Memorial Scholarship, Georgia Transplant Foundation (2010-2013)

Professional Education

  • Board Certification, American Board of Pediatrics, Pediatric Nephrology (2020)
  • Board Certification, American Board of Pediatrics, Pediatrics (2017)
  • Fellowship, Stanford University, Pediatric Nephrology (2019)
  • Residency, University of Washington, Pediatrics, Integrated Research Program (2016)
  • MD, Emory University, Medicine, Medical Scientist Training Program (2013)
  • PhD, Georgia Institute of Technology and Emory University, Biomedical Engineering (2013)
  • BS with Distinction, Yale University, Biomedical Engineering (2004)

All Publications

  • Organoid-based characterization of patient tumors and microenvironments at single cell resolution Salahudeen, A. A., Zhu, J., Ju, J., Batish, A., Sutha, K., Neal, J. T., Giangarra, V., Montesclaros, L., Sapida, J., Sharifi, O., Lee, J., Zheng, G. X., Wagh, D. A., Coller, J. A., Neal, J. W., Padda, S. K., Sabatti, C., Kuo, C. J. AMER ASSOC CANCER RESEARCH. 2018
  • Osteogenic embryoid body-derived material induces bone formation in vivo. Scientific reports Sutha, K. n., Schwartz, Z. n., Wang, Y. n., Hyzy, S. n., Boyan, B. D., McDevitt, T. C. 2015; 5: 9960


    The progressive loss of endogenous regenerative capacity that accompanies mammalian aging has been attributed at least in part to alterations in the extracellular matrix (ECM) composition of adult tissues. Thus, creation of a more regenerative microenvironment, analogous to embryonic morphogenesis, may be achieved via pluripotent embryonic stem cell (ESC) differentiation and derivation of devitalized materials as an alternative to decellularized adult tissues, such as demineralized bone matrix (DBM). Transplantation of devitalized ESC materials represents a novel approach to promote functional tissue regeneration and reduce the inherent batch-to-batch variability of allograft-derived materials. In this study, the osteoinductivity of embryoid body-derived material (EBM) was compared to DBM in a standard in vivo ectopic osteoinduction assay in nude mice. EBM derived from EBs differentiated for 10 days with osteogenic media (+β-glycerophosphate) exhibited similar osteoinductivity to active DBM (osteoinduction score = 2.50 ± 0.27 vs. 2.75 ± 0.16) based on histological scoring, and exceeded inactive DBM (1.13 ± 0.13, p < 0.005). Moreover, EBM stimulated formation of new bone, ossicles, and marrow spaces, similar to active DBM. The potent osteoinductivity of EBM demonstrates that morphogenic factors expressed by ESCs undergoing osteogenic differentiation yield a novel devitalized material capable of stimulating de novo bone formation in vivo.

    View details for DOI 10.1038/srep09960

    View details for PubMedID 25961152

    View details for PubMedCentralID PMC4426716

  • Osteogenic differentiation of stem cells alters vitamin D receptor expression. Stem cells and development Olivares-Navarrete, R. n., Sutha, K. n., Hyzy, S. L., Hutton, D. L., Schwartz, Z. n., McDevitt, T. n., Boyan, B. D. 2012; 21 (10): 1726–35


    Pluripotent and multipotent stem cells adopt an osteoblastic phenotype when cultured in environments that enhance their osteogenic potential. Embryonic stem cells differentiated as embryoid bodies (EBs) in osteogenic medium containing β-glycerophosphate exhibit increased expression of bone markers, indicating that cells are osteoblastic. Interestingly, 1α,25-dihydroxyvitaminD3 (1,25D) enhances the osteogenic phenotype not just in EBs but also in multipotent adult mesenchymal stem cells (MSCs). 1,25D acts on osteoblasts via classical vitamin D receptors (VDR) and via a membrane 1,25D-binding protein [protein disulfide isomerase family A, member 3 (PDIA3)], which activates protein kinase C-signaling. The aims of this study were to determine whether these receptors are regulated during osteogenic differentiation of stem cells and if stem cells and differentiated progeny are responsive to 1,25D. mRNA and protein levels for VDR, PDIA3, and osteoblast-associated proteins were measured in undifferentiated cells and in cells treated with osteogenic medium. Mouse EBs expressed both VDR and PDIA3, but VDR increased as cells underwent osteogenic differentiation. Human MSCs expressed Pdia3 at constant levels throughout differentiation, but VDR increased in cells treated with osteogenic medium. These results suggest that both 1,25D signaling mechanisms are important, with PDIA3 playing a greater role during early events and VDR playing a greater role in later stages of differentiation. Understanding these coordinated events provide a powerful tool to control pluripotent and multipotent stem cell differentiation through induction medium.

    View details for DOI 10.1089/scd.2011.0411

    View details for PubMedID 22034957

    View details for PubMedCentralID PMC3376455